HomeHLN • NYSE
add
Haleon PLC - ADR
Previous close
$9.66
Day range
$9.44 - $9.54
Year range
$8.86 - $11.42
Market cap
42.67B USD
Avg Volume
12.98M
P/E ratio
22.86
Dividend yield
1.86%
In the news
Financials
Income Statement
Revenue
Net income
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.74B | -1.26% |
Operating expense | 1.16B | 0.43% |
Net income | 403.00M | 33.00% |
Net profit margin | 14.71 | 34.71% |
Earnings per share | — | — |
EBITDA | 696.50M | -3.06% |
Effective tax rate | 24.37% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 676.00M | 27.31% |
Total assets | 31.83B | -4.70% |
Total liabilities | 15.83B | -5.15% |
Total equity | 16.00B | — |
Shares outstanding | 8.99B | — |
Price to book | 5.46 | — |
Return on assets | 4.78% | — |
Return on capital | 6.20% | — |
Cash Flow
Net change in cash
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 403.00M | 33.00% |
Cash from operations | 513.50M | — |
Cash from investing | -38.00M | — |
Cash from financing | -1.26B | — |
Net change in cash | -790.50M | — |
Free cash flow | 369.81M | — |
About
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
Founded
Jul 18, 2022
Website
Employees
24,561
